Indirubin-3′-monoxime 25 mg | Purity Not Available
StressMarq Biosciences
Indirubin-3′-monoxime
Search Results
(±)10-HDHA 50 µg | ≥98%
Cayman Chemical
An autoxidation product of DHA and potential marker of oxidative stress
More Information Supplier Page(±)10-HDHA
(±)10-HDHA 25 µg | ≥98%
Cayman Chemical
An autoxidation product of DHA and potential marker of oxidative stress
More Information Supplier Page(±)10-HDHA
(±)10-HDHA 1 mg | Purity Not Available
TargetMol
(±)10-HDHA is an autoxidation product of docosahexaenoic acid (DHA) in vitro.[1][2] It is also produced from incubations of DHA in rat liver, brain, and intestinal microsomes.[3][4][5] (±)10-HDHA is a potential marker of oxidative stress in brain and retina where DHA is an abundant polyunsaturated fatty acid.
More Information Supplier Page(±)10-HDHA
(±)10-Hdohe inquiry | 96%
Alfa Chemistry
(±)10,11-EDT 100 µg | ≥98%
Cayman Chemical
(±)10,11-EDT
(±)10,11-EDT 25 µg | ≥98%
Cayman Chemical
(±)10,11-EDT
(±)10,11-EDT 50 µg | ≥98%
Cayman Chemical
(±)10,11-EDT
(±)10,11-EDT 500 µg | ≥98%
Cayman Chemical
(±)10,11-EDT
(±)10(11)-DiHDPA 1 mg | ≥98%
Cayman Chemical
(±)10(11)-DiHDPA
(±)10(11)-DiHDPA 1 mg | Purity Not Available
TargetMol
(±)10(11)-DiHDPA is produced from cytochrome P450 epoxygenase action on docosahexaenoic acid . It has been shown to inhibit VEGF-induced angiogenesis in mice and may have additional anti-inflammatory and anti-tumor effects.
More Information Supplier Page(±)10(11)-DiHDPA
